BeOne Medicines Ltd. American Depositary Shares (ONC) Stock Price

ONCStock
$376.37+20.61%52W
Market Cap$42.58B
P/E190.82x
PEG Ratio
Div yield
Beta1.29

ONC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-15.06%
Price vs S&P 500 (4W)-0.63%
VGM Score54.69
P/E Ratio (Annual)190.82x

ONC Earnings Surprise History

Q2 250.12est. 0.04
Q3 250.16est. 0.13
Q4 250.09est. 0.19
Q1 260.29est. 0.12
Q2 260.30est. 0.24

ONC Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.13
4.17
4.17
4.17

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ONCBeOne Medicines Ltd. American Depositary Shares
DBC$376.37
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About BeOne Medicines Ltd. American Depositary Shares

BeOne Medicines is an oncology-focused biopharmaceutical company that discovers, develops, and commercializes targeted cancer treatments. The company's portfolio includes BRUKINSA (a Bruton's tyrosine kinase inhibitor), sonrotoclax (a BCL2 inhibitor), and other proprietary therapeutics. BeOne generates revenue primarily from the sale of its biopharmaceutical products across multiple oncology indications.